Share this post on:

Product Name :
PI-3065

Search keywords :
PI-3065

drugId :
null

Target Vo:
Phosphatidylinositol 3 kinase delta

Target Vo Short Name :
PI3Kδ

Moa_Name:
Phosphatidylinositol 3 kinase delta inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University College London

Active Company_Name :
Piramed

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Farletuzumab medchemexpress
Marstacimab References
Glucose Transporter GLUT4 Antibody (YA753): Glucose Transporter GLUT4 Antibody (YA753) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to Glucose Transporter GLUT4. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related